Valuing morbidity: An integration of the willingness-to-pay and health- status index literatures

Journal of Health Economics

Volumn 16, Issue 6, 1997, Pages 641-665

  Reed Johnson, F ^a   Fries, Erin E ^a   Spencer Banzhaf, H ^b  

^a Triangle Economic Research   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH STATUS; MEDICAL LITERATURE; MORBIDITY;

ACTIVITIES OF DAILY LIVING; CONSUMER SATISFACTION; HEALTH POLICY; HEALTH STATUS INDICATORS; HUMANS; MODELS, ECONOMIC; MORBIDITY; VALUE OF LIFE;

EID: 0344193104     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-6296(97)00012-X     Document Type: Article

References (77)

1. Alberini, A., Cropper, M., Fu, T-T., Krupnick, A., Liu, J.-T., Shaw, D., Harrington, W., 1994. Valuing health effects of air pollution in developing economies: The case of Taiwan. Discussion Paper 95-01, Resources for the Future.
2. Berger, M.C., Bloomquist, G.C., Kenkel, D., Tolley, G.S., 1987. Valuing changes in health risks: A comparison of alternative measures. Southern Econ. J. 53 (4), 967-984.
3. Bergner, M., 1993. Development, testing, and use of the sickness impact profile. In: Walker, S.R., Rosser, R.M. (Eds.), Quality of Life Assessment: Key Issues in the 1990s. Kluwer Academic Publishers, Dordrecht, pp. 95-110.
4. Boyle, K.J., Poe, G.L., Bergstrom, J.C., 1994. What do we know about groundwater values? Preliminary implications from a meta-analysis of contingent valuation studies. Am. J. Agricultural Econ. 76, 1055-1061.
5. Brien, M., Kenkel, D., Kelly, A., Fabian, R., 1994. Empirical results from household personal interviews. In: Tolley, G., Kenkel, D., Fabian, R. (Eds.), Valuing Health for Policy: An Economic Approach. University of Chicago Press, Chicago, pp. 167-190.
6. Bush, J.W., Chen, M.M., Patrick, D.L., Blischke, W.R., 1973. Linear models of social preferences for constructing a health status index. Report prepared for the Bureau of Health Services Research. University of California at San Diego. La Jolla, CA.
7. Bush, J.W., Fanshel, S., Chen, M.M., 1972. Analysis of a tuberculin testing program using a health status index. Socio-Economic Planning Sci. 6 (1), 49-68.
8. Chestnut, L.G., Colome, S.D., Keller, L.R., Lambert, W., Ostro, B., Rowe, R.D., Wojciechowski, S.L., 1988. Heart disease patients' averting behavior, costs of illness, and willingness to pay to avoid angina episodes. Final report prepared for US Environmental Protection Agency, Document No. EPA-230-10-88-042.
9. Cropper, M.L., 1981. Measuring the benefits from reduced morbidity. Am. Econ. Rev. 71 (2), 235-240.
10. Cropper, M.L., Freeman, A.M., III, 1991. Environmental health conditions. In: Braden, J.B., Kolstad, C.D. (Eds.), Measuring the Demand for Environmental Quality. North-Holland, Amsterdam.
11. Desvousges, W.H., Reed Johnson, F., Spencer Banzhaf, H., Russell, R.R., Fries, E.E., Dietz, K.J., Helms, S.C., Keen, D., Snyder, J., Balentine, H., Sadeghi, V., Martin, S.A., 1995. Assessing environmental externality costs for electricity generation. Final report prepared for Northern States Power Company, May. Triangle Economic Research, Durham, NC.
12. Desvousges, W.H., Reed Johnson, F., Hudson, S.P., Gable, A.R., Ruby, M.C., 1996. Using conjoint analysis and health-state classifications to estimate the value of health effects of air pollution: Pilot test results and implications. Draft report prepared for Environment Canada, Health Canada, Ontario Hydro, Ontario Ministry of Environment and Energy, and Quebec Ministry of Environment. Triangle Economic Research, Durham, NC.
13. Dickie, M., Gerking, S., 1991. Willingness to pay for ozone control: Inferences from the demand for medical care. J. Environ. Econ. Manage. 21 (1), 1-16.
14. Dickie, M., Gerking, S., Brookshire, D., Coursey, D., Schulze, W., Coulson, A., Tashkin, D., 1987. Reconciling averting behavior and contingent valuation benefit estimates of reducing symptoms of ozone exposure. In: Improving Accuracy and Reducing Costs of Environmental Benefit Assessment. US Environmental Protection Agency, Washington, DC; Dickie, M., Gerking, S., Schulze, W., Coulson, A., Tashkin, D., 1987. Value of symptoms of ozone exposure: An application of the averting behavior method. In: Improving Accuracy and Reducing Costs of Environmental Benefit Assessments. US Environmental Protection Agency, Washington, DC.
15. Dickie, M., Gerking, S., Brookshire, D., Coursey, D., Schulze, W., Coulson, A., Tashkin, D., 1987. Reconciling averting behavior and contingent valuation benefit estimates of reducing symptoms of ozone exposure. In: Improving Accuracy and Reducing Costs of Environmental Benefit Assessment. US Environmental Protection Agency, Washington, DC; Dickie, M., Gerking, S., Schulze, W., Coulson, A., Tashkin, D., 1987. Value of symptoms of ozone exposure: An application of the averting behavior method. In: Improving Accuracy and Reducing Costs of Environmental Benefit Assessments. US Environmental Protection Agency, Washington, DC.
16. Dickie, M., Gerking, S., McClelland, G., Schulze, W., 1988. Contingent valuation: The value formation process, Mimeo.
17. Edelson, J.T., Weinstein, M.C., Tosteson, A.N., Williams, L., Lee, T.H., Goldman, L., 1990. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. J. Am. Med. Ass. 263, 407-413.
18. Elixhauser, A., et al., 1993. Health care CBA/CEA: An update on the growth and composition of the literature, Medical Care (July supplement) 31(7): JS1-JS11.
19. Fanshel, S., Bush, J.W., 1970. A health-status index and its application to health-services outcome. Oper. Res. 18 (6), 1021-1066.
20. Fisher, A., 1984. Environmental Protection Agency. In: Kerry Smith, V. (Ed.), Environmental Policy under Reagan's Executive Order, the Role of Benefit-Cost Analysis, University of North Carolina Press.
21. Freeman, A.M., Burtraw, D., Harrington, W., Krupnick, A., 1992. Weighing environmental externalities: How to do it right. The Electricity Journal (August/September), 18-25.
22. Froberg, D.G., Kane, R.L., 1989. Methodology for measuring health-state preferences, I: Measurement strategies. J. Clinical Epidemiology 42 (4), 345-354.
23. Gerking, S., de Haan, M., Schulze, W., 1988. The marginal value of job safety: A contingent valuation study. J. Risk and Uncertainty 1 (2), 185-200.
24. Gerking, S., Stanley, L.R., 1986. An economic analysis of air pollution and health: the case of St. Louis. Rev. Econ. Stat. 68 (1), 115-121.
25. Greene, W.H., 1993. Econometric analysts, 2nd ed. MacMillan, New York.
26. Grossman, M., 1972. On the concept of health capital and the demand for health. J. Political Econ. 80, 223-255.
27. Hanemann, M.W., 1996. The economic theory of WTP and WTA. Working Paper.
28. Harrison, D., Jr., Nichols, A.L., Bittenbender, S.L., Berkman, M.P., 1993. External costs of electric utility resource selection in Nevada, Report prepared for Nevada Power Company. National Economic Research Associates, Inc., Cambridge, MA.
29. Hausman, J.A., 1993. Contingent Valuation: A Critical Assessment. Elsevier Science B.V., Amsterdam.
30. Hedges, L.V., Olkin, I., 1985. Statistical methods for meta-analysis. Academic Press, San Diego.
31. Johannesson, M., 1995. The cost-effectiveness of hypertension treatment in Sweden. PharmacoEconomics 7, 242-250.
32. Johannesson, M., Jönsson, B., Borgquist, L., 1991. Willingness to pay for antihypertensive therapy: Results of a Swedish pilot study. J. Health Econ. 10: 461-473; Johannesson, M., Aberg, H., Agreus, L., Borgquist, L., Jönsson, B., 1991. Cost-benefit analysis of non-pharmacological treatment of hypertension. J. Internal Med. 230: 307-312.
33. Johannesson, M., Jönsson, B., Borgquist, L., 1991. Willingness to pay for antihypertensive therapy: Results of a Swedish pilot study. J. Health Econ. 10: 461-473; Johannesson, M., Aberg, H., Agreus, L., Borgquist, L., Jönsson, B., 1991. Cost-benefit analysis of non-pharmacological treatment of hypertension. J. Internal Med. 230: 307-312.
34. Johannesson, M., Johansson, P., Kriström, B., Gerdtham, U., 1993. Willingness to pay for antihypertensive therapy-further results. J. Health Econ. 12, 95-108.
35. Johnson, F. Reed, Fries, E.E., Spencer Banzhaf, H., 1996. Valuing morbidity: An integration of the willingness-to-pay and health-status literatures, TER Technical Working Paper No. T-9601. Triangle Economic Research, Durham, NC.
36. Kaplan, R.M., Bush, J.W., 1982. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology 1 (1), 61-80.
37. Kaplan, R.M., Ernst, J.A., 1983. Do category rating scales produce biased preferences weights for a health index?. Med. Care 21 (2), 193-207.
38. Kaplan, R.M., Anderson, J.P., 1988. A general health policy model: Update and applications. Health Services Res. 23 (2), 203-235.
39. Kaplan, R.M., Anderson, J.P., 1990. The general health policy model: An integrated approach. In: Spilker, B. (Ed.), Quality of Life Assessments in Clinical Trials. Raven Press, New York, pp. 131-149.
40. Kaplan, R.M., Bush, J.W., Berry, C.C., 1976. Health status: Types of validity and the index of well-being. Health Services Res. 11 (4), 478-507.
41. Kaplan, R.M., Bush, J.W., Berry, C.C., 1978. The reliability, stability, and generalizability of a health status index, Paper presented at the annual meeting of the American Statistical Association, Social Statistics Section.
42. Kaplan, R.M., Anderson, J.P., Ganiats, T.G., 1993. The quality of well-being scale: Rationale for a single quality of life index. In: Walker, S.R., Rosser, R.M. (Eds.), Quality of Life Assessment: Key Issues in the 1990s. Kluwer Academic Publishers, Dordrecht.
43. Kaplan, R.M., Anderson, J.P., Patterson, T.L., McCutchan, J.A., Weinrich, J.D., Heaton, R.K. Atkinson, J.H., Thai, L., Chandler, J., Grant, I., the HNRD Group, 1995. Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. Psychosomatic Med. 57: 138-147.
44. Krupnick, A., Cropper, M., 1992. The effect of information on health risk valuations. J. Risk and Uncertainty 5, 29-48.
45. Krupnick, A.J., Kopp, R.J., 1988. The health and agricultural benefits of reductions in ambient ozone in the United States, Discussion paper QE88-10. Resources for the Future, Washington, DC.
46. L'Abbe, K.A., Detsky, A.S., O'Rourke, K., 1987. Meta-analysis in clinical research. Ann. Internal Med. 107, 224-233.
47. Loehman, E.T., Berg, S.V., Arroyo, A.A., Hedinger, R.A., Schwartz, J.M., Shaw, M.E., Fahien, R.W., De, V.H., Fishe, R.P., Rio, D.E., Rossley, W.F., Green, A.E.S., 1979. Distributional analysis of regional benefits and cost of air quality control. J. Environmental Econ. Manage. 6, 222-243.
48. Mauskopf, J.A., French, M.T., 1991. Estimating the value of avoiding morbidity and mortality from foodborne illnesses. Risk Analysis 11 (4), 619-631.
49. Mehrez, A., Gafni, A., 1989. Quality adjusted life years (QALYs), utility theory, and healthy years equivalent. Med. Decision Making 9, 142-149.
50. Mitchell, R.C., Carson, R.T., 1989. Using surveys to value public goods: The contingent valuation method. Resources for the Future, Washington, DC.
51. Oregon Health Services Commission, 1991. Prioritization of health services: A report to the governor and legislature, Portland, Oregon.
52. Patrick, D.L., Bush, J.W., Chen, M.M., 1973. Methods for measuring levels of well-being for a health status index. Health Services Res. 8 (2), 228-245.
53. Randall, A., Stoll, J.R., 1980. Consumer's surplus in commodity space. Am. Econ. Rev., 449-457.
54. Rosenthal, D.H., Nelson, R.H., 1992. Why existence value should not be used in cost-benefit analysis. J. Policy Analysis Manage. 11 (1), 116-122.
55. Rosser, R., Sintonen, H., 1993. The Euroquol© quality of life project. In: Walker, S.R., Rosser, R.M. (Eds.), Quality of Life Assessment: Key Issues in the 1990s. Kluwer Academic Publishers, Dordrecht, pp. 197-199.
56. Rowe, R.D., Lang, C.M., Chestnut, L.G., Latimer, D., Rae, D., Bernow, S.M., White, D., Forthcoming in late 1995. The New York Electricity Externality Study. Oceana Publications, Dobbs Ferry, NY.
57. Rowe, R.D., Chestnut, L.G., 1985. Oxidants and asthmatics in Los Angeles: A benefits analysis, Final report prepared for U.S. EPA. Document No. EPA-230-7-85-010.
58. Schulman, K.A., Lynn, L.A., Glick, H.A., Eisenberg, J.M., 1991. Cost-effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infections. Ann. Internal Med. 114, 798-802.
59. Schwartz, J., Hasselblad, V., Pitcher, H., 1988. Air pollution and morbidity: A further analysis of the Los Angeles student nurses data. J. Air Pollution Control Administration 38, 158-162.
60. Sintonen, H., Pekurinen, M., 1993. A fifteen-dimensional measure of health-related quality of life (15D) and its applications. In: Walker, S.R., Rosser, R.M. (Eds.), Quality of Life Assessment: Key Issues in the 1990s, Kluwer Academic Publishers, Dordrecht.
61. Sintonen, H., Allander, V., 1990. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers. J. Health Econ. 9, 85-101.
62. Smith, V.K., Osborne, L., 1995. Contingent valuation estimates pass a 'scope' test? A Meta-analysis, Working Paper.
63. Smith, V.K., Huang, J.-C., 1993. Hedonic models and air pollution: Twenty-five years and counting. Environmental and Resource Econ. 3, 381-394.
64. Smith, V.K., Yoshiaki, K., 1990. Signals or noise? Explaining the variation in recreation benefit estimates. Am. J. Agricultural Econ. 72, 419-433.
65. Spitzer, W.O., 1991. Meta-meta-analysis: Unanswered questions about aggregating data. J. Clinical Epidemiology 44 (2), 103-107.
66. Tengs, T.O., Adams, M.E., Pliskin, J.S., Gelb Safran, D., Siegel, J.E., Weinstein, M.C., Graham, J.D., 1995. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 15 (3), 369-390.
67. Thacker, S.B., 1988. Meta-analysis: A quantitative approach to research integration. J. Am. Med. Ass. 259 (11), 685-1689.
68. Thompson, M.S., Read, J.L., Liang, M., 1984. Feasibility of willingness-to-pay measurement in chronic arthritis. Med. Decision Making 4 (2), 195-215.
69. Tolley, G., Kenkel, D., Fabian, R., 1994. State-of-the-art health values, In: Tolley, G., Kenkel, D., Fabian, R. (Eds.), Valuing Health for Policy: An Economic Approach. University of Chicago Press, Chicago, pp. 167-190.
70. Tolley, G., Babcock, L., Berger, M., Bilotti, A., Blomquist, G., Brien, M., Fabian, R., Fishelson, G., Kahn, C., Kelly, A., Kenkel, D., Krumm, R., Miller, T., Ohsfeldt, R., Rosen, S., Webb, W., Wilson, W., Zelder, M., 1986. Valuation of reductions in human health symptoms and risk. In: Contingent valuation study of light symptoms and angina, vol. 3, Final report prepared for US Environmental Protection Agency.
71. Torrance, G.W., 1986. Measurement of health state utilities for economic appraisal. J. Health Econ. 5, 1-30.
72. Torrance, G.W., 1987. Utility approach to measuring health-related quality of life. J. Chronic Disease 40 (6), 593-600.
73. van Hout, B., Bonsel, G., Habbema, D., van der Maas, P., de Charro, F., 1993. Heart transplantation in the Netherlands; Costs, effects, and scenarios. J. Health Econ. 12, 73-93.
74. Viscusi, W.K., Magat, W.A., Huber, J., 1991. Pricing environmental health risks: Survey assessments of risk-risk and risk-dollar tradeoffs for chronic bronchitis. J. Environmental Econ. Manage. 21 (July), 32-51.
75. Wachter, K.W., 1988. Disturbed by meta-analysis?. Science 241, 1407-1408.
76. Weisbrod, B.A., 1981. Benefit-cost analysis of a controlled experiment: Treating the mentally ill. J. Human Res. 16 (4), 523-548.
77. Wu, A.W., Matthews, W.C., Brysk, L.T., Atkinson, J.H., Grant, I., Abrmson, I., Kennedy, C.J., McCutchan, J.A., Spector, S.A., Richman, D.D., 1990. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J. Acquired Immune Deficiency Syndromes 3 (7), 683-690.